日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

在正在进行的MONARCH开放标签扩展研究中,评估了类风湿性关节炎患者从阿达木单抗转换为沙利鲁单抗的安全性和有效性。

Burmester, Gerd R; Strand, Vibeke; Rubbert-Roth, Andrea; Amital, Howard; Raskina, Tatiana; Gómez-Centeno, Antonio; Pena-Rossi, Claudia; Gervitz, Leon; Thangavelu, Karthinathan; St John, Gregory; Boklage, Susan; Genovese, Mark C

A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol

一项比较疾病活动度指标在评估和预测类风湿关节炎患者接受赛妥珠单抗治疗反应中的随机试验

Curtis, Jeffrey R; Churchill, Melvin; Kivitz, Alan; Samad, Ahmed; Gauer, Laura; Gervitz, Leon; Koetse, Willem; Melin, Jeffrey; Yazici, Yusuf

Systemic hypoxia and the depression of synaptic transmission in rat hippocampus after carotid artery occlusion

颈动脉闭塞后大鼠海马体出现全身性缺氧和突触传递抑制

Fowler, J C; Gervitz, L M; Hamilton, M E; Walker, J A